Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients

ClinicalTrials.gov ID: NCT00550459

Public ClinicalTrials.gov record NCT00550459. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 7:02 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Demonstrate an improvement in the composite scores of validated neurocognitive tests in elderly subjects with chronic sub-clinical (i.e., asymptomatic) hyponatremia.

Study identification

NCT ID
NCT00550459
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
57 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2007 (Type not available)
Primary completion
Feb 2009 (Actual)
Completion
Mar 2009 (Actual)
Last update posted
Apr 28, 2011

2007 – 2009

United States locations

U.S. sites
12
U.S. states
10
U.S. cities
12
Facility City State ZIP Site status
Sarah. S. Olelewe, MD Hawthorne California 90250 —
Progressive Clinical Research Vista California 92083 —
Pikes Peak Cardiology Colorado Springs Colorado 80907 —
Innovative Research of West FL Largo Florida 33770 —
Coastal Nephrology Assoc. Research Center Punta Gorda Florida 33950 —
Rockdale Medical Research Associates Conyers Georgia 30094 —
Otis Barnum, DO Natchitoches Louisiana 71457 —
Lillestol Research, LLC Fargo North Dakota 58106 —
Carolina Research Associates Columbia South Carolina 29201 —
Wayne O. Wells, MD Lebanon Tennessee 37087 —
Memorial Clinical Associates Houston Texas 77043 —
Mitchell Rosner, MD Charlottesville Virginia 22908 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00550459, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 28, 2011 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00550459 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →